Friday, October 19
1:00 PM - 2:00 PM

Keynote Speech: Advanced development for long-term, fully implantable glucose sensors

Andrew DeHennis, Ph.D.

Director, Engineering, Research & Development Senseonics, Incorporated, USA


Dr. DeHennis has achieved degrees in both Physics and Electrical Engineering with focuses on Solid-State Devices as well as Micro-Electro Mechanical Systems (MEMS). His Ph.D. from the University of Michigan in 2004 focused on wireless sensors that spanned applications in biomedical as well as environmental monitoring systems. He has spent his professional career working to make long-term implantable analyte sensing a reality in achieving the launch of the Eversense Continuous Glucose Monitoring (CGM) system. His team’s current work focuses on scale-up and support of the Eversense system, continued R&D in system architecture and algorithm development, as well as clinical evaluation and regulatory strategy for next-generation CGM systems. Spanning his academic and professional career, he has over two dozen published papers and patents in the field of sensors, which span the technological building blocks and long-term in vivo performance and characterization of the Eversense CGM system.